Proactive pharmaceutical care interventions decrease patients' nonadherence to osteoporosis medication.

G G Stuurman-Bieze, A; G Hiddink, E; F M van Boven, J; Vegter, S

doi:10.1007/s00198-014-2659-8

Public

Proactive pharmaceutical care interventions decrease patients' nonadherence to osteoporosis medication.

Published in Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA • Jun 1, 2014

NobleIDark:/48914/w1/20260526/D29A1DEERecord on NobleID

Authors:

A G G Stuurman-Bieze

,

E G Hiddink

,

J F M van Boven

Abstract

Using a protocolled intervention program, pharmacists can decrease nonadherence to osteoporosis medication, by continuous monitoring and tailored counseling sessions, starting at treatment initiation. In the usual care group, 32.8% of patients initiating osteoporosis medication discontinued or were ...

Discussions